Biodesix (BDSX) Gross Profit (2019 - 2026)

Biodesix (BDSX) has reported Gross Profit for 8 consecutive years, with $21.3 million the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $21.3 million, up 49.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.8 million (up 23.25% YoY), and the FY2025 annual result was $80.9 million, up 26.96% from the prior year.
• Gross Profit was $21.3 million for Q1 2026 at Biodesix, down from $26.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $26.8 million in Q4 2025 and troughed at $3.3 million in Q1 2022.
• Average Gross Profit over 5 years is $13.0 million, with a median of $12.7 million recorded in 2024.
• Year-over-year, Gross Profit plunged 68.89% in 2022 and soared 115.2% in 2024.
• Over 5 years, Gross Profit stood at $6.3 million in 2022, then jumped by 79.24% to $11.3 million in 2023, then soared by 113.26% to $24.1 million in 2024, then gained by 11.24% to $26.8 million in 2025, then slipped by 20.32% to $21.3 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $21.3 million in Q1 2026, $26.8 million in Q4 2025, and $17.7 million in Q3 2025.